Tech Center 1600 • Art Units: 1643 1645 1699
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18183042 | ENGINEERED ANTIBODIES AND USES THEREOF | Non-Final OA | The Regents of the University of California |
| 18150466 | ALTERNATIVE SURFACTANTS AS STABILIZERS FOR THERAPEUTIC PROTEIN FORMULATIONS | Final Rejection | Hoffmann-La Roche Inc. |
| 16979209 | COMPOSITIONS AND METHODS FOR DETECTING MYCOBACTERIUM TUBERCULOSIS | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 17769113 | CHAGAS DISEASE VACCINE ANTIGENS WITH IMPROVED STABILITY AND DECREASED AGGREGATION | Non-Final OA | Baylor College of Medicine |
| 18292771 | COMPOSITION COMPRISING A PARTICULAR ANTIOXIDANT, A SPECIFIC FATTY ACID ESTER, A BIFIDOBACTERIUM SPECIES LYSATE AND A YEAST EXTRACT | Non-Final OA | L'Oreal |
| 18033813 | PROTEINS FOR THE DETECTION OF SCHISTOSOMA INFECTION | Non-Final OA | MERCK PATENT GMBH |
| 18258550 | IMPLANTABLE CONSTRUCTS FOR MODULATING AN IMMUNE RESPONSE | Non-Final OA | William Marsh Rice University |
| 18002245 | METHOD FOR OBTAINING A COMPOSITION COMPRISING HUMAN PLASMA-DERIVED IMMUNOGLOBULIN M | Non-Final OA | GRIFOLS WORLDWIDE OPERATIONS LIMITED |
| 17680155 | LIQUID PHARMACEUTICAL COMPOSITION | Non-Final OA | FRESENIUS KABI DEUTSCHLAND GMBH |
| 18357065 | COMPOSITIONS AND METHODS FOR DETECTING TRYPANOSOMA CRUZI INFECTION | Non-Final OA | University of Georgia Research Foundation, Inc. |
| 18599008 | BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION | Non-Final OA | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 16771510 | Inducible Cell Receptors for Cell-Based Therapeutics | Non-Final OA | Trustees of Boston University |
| 18427000 | MANUFACTURING METHODS FOR PRODUCING ANTI-IL12/IL23 ANTIBODY COMPOSITIONS | Final Rejection | Janssen Biotech, Inc. |
| 17771420 | THERANOSTICS FOR HYPERTENSION INDUCED MYOCARDIAL MICROBLEEDS | Non-Final OA | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE |
| 18625004 | ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS | Non-Final OA | TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz |
| 17632270 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | Final Rejection | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18564618 | INDICATOR MOLECULE FOR TOXIGENICITY OF AFLATOXIGENIC FUNGI AND USE THEREOF | Non-Final OA | OIL CROPS RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES |
| 17675775 | VARIANT FC DOMAINS AND USES THEREOF | Non-Final OA | Cidara Therapeutics, Inc. |
| 17915661 | COMPOSITION FOR IMPROVING SKIN WRINKLE, MOISTURIZING, STRENGTHENING SKIN BARRIER, AND PROMOTING SKIN REGENERATION, COMPRISING MIXED LACTIC ACID BACTERIA AS ACTIVE INGREDIENT | Non-Final OA | PFNATURE CO., LTD. |
| 16428856 | ANTI-PVRIG/ANTI-TIGIT BISPECIFIC ANTIBODIES AND METHODS OF USE | Non-Final OA | Compugen Ltd. |
| 18187377 | THERAPEUTIC MOLECULES | Final Rejection | PetMedix Ltd |
| 18023492 | ANTITUMOR BACTERIAL STRAIN, AND COMPOSITION AND METHOD USING SAME | Non-Final OA | LIVEOME INC. |
| 17758399 | PROGRAMMED CELL DEATH RECEPTOR 1 ANTIBODY FORMULATION AND USE THEREOF | Final Rejection | SHANGHAI HENLIUS BIOTECH, INC. |
| 17255570 | METHODS OF TREATING OR PREVENTING MUCORMYCOSIS | Non-Final OA | Los Angeles Biomedical Research Institute at Harbor at UCLA Medical Center |
| 16823313 | INSECT PRODUCTION SYSTEMS AND METHODS | Non-Final OA | INSECTERGY US LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy